Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice
Phytotherapy Research · 2025-04 · 39 (4) · 1663-1678
DOI: 10.1002/ptr.8010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 11.09.2023. Verfasst von Wen-Jing Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Fujian Key Laboratory of Chinese Materia Medica, Fujian University of Traditional Chinese Medicine, Fuzhou, China. Hauptthemen laut MEDLINE: Flavonoids, Oxidative Stress, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Collaborative Innovation Platform Project of Fuxiaquan National Innovation Demonstration Zone, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic dysfunction‐associated fatty liver disease (MAFLD) is the main cause of chronic liver disease. Baicalin (Bai), a bioactive molecule found in Scutellaria baicalensis Georgi, possesses antioxidant and antiinflammatory properties. These activities suggest Bai could be a promising therapeutic agent against NAFLD; however, its specific effects and underlying mechanism are still not clear. This study aims to explore the effect of Bai to attenuate MAFLD and associated molecular mechanisms. Bai (50, 100 or 200 mg/kg) was orally administered to db / db mice with MAFLD for 4 weeks or db/m mice as the normal control. Bai markedly attenuated lipid accumulation, cirrhosis and hepatocytes apoptosis in the liver tissues of MAFLD mice, suggesting strong ability to attenuate MAFLD. Bai significantly reduced proinflammatory biomarkers and enhanced antioxidant enzymes, which appeared to be modulated by the upregulated p62‐Keap1‐Nrf2 signalling cascade; furthermore, cotreatment of Bai and all‐trans‐retinoic acid (Nrf2 inhibitor) demonstrated markedly weakened liver protective effects by Bai and its induced antioxidant and antiinflammatory responses. The present study supported the use of Bai in attenuating MAFLD as a promising therapeutic agent, and its strong mechanism of action in association with the upregulating the p62‐keap1‐Nrf2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Fujian Key Laboratory of Chinese Materia Medica, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
- NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia.
- Science and Technology Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
ORCID-Profile: Yan-Fang Zheng, Xian Zhou
Förderung
- Collaborative Innovation Platform Project of Fuxiaquan National Innovation Demonstration Zone
- National Natural Science Foundation of China
Zitieren
APA
Liu, W. J., Chen, W. W., Chen, J. Y., Sun, Y. B., Chang, D., Wang, C. X., Xie, J. D., Lin, W., Li, S. H., Xu, W., Lin, Y. X., Zheng, Y. F., Zhou, X., & Huang, M. Q. (2025). Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice. Phytotherapy Research, 39(4), 1663-1678. https://doi.org/10.1002/ptr.8010
Vancouver
Liu WJ, Chen WW, Chen JY, Sun YB, Chang D, Wang CX, et al. Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice. Phytotherapy Research. 2025;39(4):1663-1678. doi:10.1002/ptr.8010
BibTeX
@article{Liu2025,
author = {Liu, Wen-Jing and Chen, Wei-Wen and Chen, Jia-Ying and Sun, Yi-Bin and Chang, Dennis and Wang, Chen-Xiang and Xie, Jin-Dong and Lin, Wei and Li, Shao-Hua and Xu, Wen and Lin, Yan-Xiang and Zheng, Yan-Fang and Zhou, Xian and Huang, Ming-Qing},
title = {Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {4},
pages = {1663--1678},
doi = {10.1002/ptr.8010}
}
EUVIMED